Pfizer's coronavirus vaccine is mass administered to people in the UK for the first time in the world. A 90-year-old woman was the first.
Vaccination against coronavirus begins in the United Kingdom. Early in the morning on Tuesday, December 8, Margaret Keenan, a woman from Northern Ireland, has become the first person in the world to receive the Pfizer/BioNTech vaccine outside of clinical trials. "It is the best anticipated birthday gift I could wish for because it means that I can finally look forward to spending time with my family and friends in the new year, after being alone for most of the year," said Margaret Keenan on leaving the medical center.
Finally, after thanking the hospital staff for the treatment received, he left advice for those who have doubts about the vaccine: "My advice to anyone who is offered the vaccine is to take it; if I can have it at 90, you can have it too."
Another of the first to receive the Pfizer vaccine was 81-year-old William Shakespeare, who has nothing to do with the famous British playwright and poet. In his case, he was vaccinated in Coventry, about 30 kilometers from the city where his historic compatriot, Stratford-upon-Avon, was born.
The first country to administer it
With this fact, the United Kingdom becomes the first country to supply the population with Pfizer's vaccine against the coronavirus. Last week, the UK regulatory body authorized their use, which can be followed by for the rest of Europe and the United States in the coming days.
Health Secretary Matt Hanock told BBC Breakfast, "We have a long march ahead of us, but this marks the exit. This virus is deadly; we have to stick to the rules."
For his part, the British Prime Minister, Boris Johnson, also shared his impressions of this and its importance. "The UK's first Covid-19 vaccines begin today. Thanks to our NHS, all the scientists who worked so hard to develop this vaccine, all the volunteers and everyone who has followed the rules to protect others. We will get through it together."
The British Government purchased 800,000 doses of the vaccine for the next few weeks, which will serve to immunize 400,000 people since the treatment consists of two doses. In total, orders of up to 40 million vials have been placed, with a view to the beginning of the new year. In this first group of vaccination will be applied those over 80 years.